Synergia
Brussels, BE · 1 known investors
Find your way into Synergia
1,229 people in our graph share verified history with the Synergia team — schools, employers, funds. One of them is your warm intro.
Teresa Chanunlockedknows Dan Scherrer · together at Johnson & Johnson (overlapped)
×10knows the team · via McKinsey & Company
knows the team · via Johnson & Johnson
Synergia Medical develops optoelectronic implantable medical devices, including its NAO.VNS vagus nerve stimulation system, which is undergoing First-In-Human clinical evaluation through the AURORA study. The company is based in Belgium.
Founders & leadership
CN
Charles NoletinCEOCharles Nolet holds a degree in civil engineering from the Catholic University of Louvain and an MBA from MIT Sloan, where he specialized in MedTech; he previously worked at McKinsey & Company advising pharmaceutical and private equity clients, and at Lumine Capital Advisors supporting MedTech fundraising and growth initiatives, before becoming CEO of Synergia Medical, which develops optoelectronic implantable devices for neuromodulation.
VD
Vincent De RudderVP QARA
GK
Gijs KlarenbeekVP of Clinical
DS
Dan ScherrerinCOOHe brings over 20 years of operations experience in medical devices and manufacturing, including leadership roles at Johnson & Johnson, with expertise in product development, clinical validation, industrialization, and supply chain management across implantable technologies.
DC
Dimitri CrelotinCFO
Investors · 1
In the news
Frequently asked questions
- What does Synergia do?
- Synergia Medical develops optoelectronic implantable medical devices, including its NAO.VNS vagus nerve stimulation system, which is undergoing First-In-Human clinical evaluation through the AURORA study. The company is based in Belgium.
- Who are Synergia's investors?
- Synergia's investors include Newton Biocapital.
- Where is Synergia headquartered?
- Synergia is headquartered in Brussels, BE.